stock.name

Evolus Inc

EOLS

Market Cap$664.03M
Close$

Compare Evolus

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Evolus IncEvolus Inc-10.80%298%3.9-5.8
marketMarket Avg58.91.29%29%-1
HealthcareHealthcare Avg66.31.31%15%-0.9
$16.00

Target Price by Analysts

35.9% upsideEvolus Target Price DetailsTarget Price
$16.20

Current Fair Value

37.6% upside

Undervalued by 37.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$664.03 Million
Enterprise Value$721.55 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.08
Beta0.0
Outstanding Shares57,943,622
Avg 30 Day Volume447,744

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-10.76
PEG106.31
Price to Sales3.92
Price to Book Ratio-11.77
Enterprise Value to Revenue3.57
Enterprise Value to EBIT-19.98
Enterprise Value to Net Income-12
Total Debt to Enterprise0.17
Debt to Equity-5.82

Revenue Sources

No data

ESG Score

No data

About Evolus Inc

CEO: David Moatazedi